Amplification and protein expression of androgen receptor gene in prostate cancer cells: Fluorescence in situ hybridization analysis

Oncology Letters

Volumn 9, Issue 6, 2015, Pages 2617-2622

  Zhang, Xian ^a   Hong, Shi Zhe ^a   Lin, Er Jiang ^a   Wang, Da Ya ^a   Li, Zhi Jia ^a   Chen, Li ^a  

^a WENZHOU CENTRAL HOSPITAL   (China)

Author keywords

Amplification; Androgens; Fluorescence in situ hybridization; Immunohistochemistry; Survival

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANDROGEN RECEPTOR GENE; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MIDDLE AGED; PROSTATE CANCER; PROTEIN EXPRESSION; TISSUE MICROARRAY; TUMOR GROWTH; VERY ELDERLY; X CHROMOSOME;

EID: 84929990525     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2015.3114     Document Type: Article

References (21)

1. Lassi K and Dawson NA: Update on castrate-resistant prostate cancer: 2010. Curr Opin Oncol 22: 263-267, 2010.
2. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
3. Shahrokh F, Shariat, Axel S, et al: Tumor markers in prostate cancer I: Blood-based markers. Acta Oncol 50: 61-75, 2011.
4. Culig Z, Hobisch A, Bartsch G and Klocker H: Androgen receptor -an update of mechanisms of action in prostate cancer. Urol Res 28: 211-219, 2000.
5. Visakorpi T, Hyytinen E, Koivisto P, et al: In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 9: 401-406, 1995.
6. Cude KJ, Montgomery JS, Price DK, et al: The role of an androgen receptor polymorphism in the clinical outcome of patients with metastatic prostate cancer. Urol Int 68: 16-23, 2002.
7. Heinlein CA and Chang C: Androgen receptor in prostate cancer. Endocr Rev 25: 276-308, 2004.
8. Chen CD, Welsbie DS, Tran C, et al: Molecular determinants of resistance to antiandrogen therapy. Nat Med 10: 33-39, 2004.
9. Gelmann EP: Molecular biology of the androgen receptor. J Clin Oncol 20: 3001-3015, 2002.
10. Shaffer DR and Scher HI: Prostate cancer: a dynamic illness with shifting targets. Lancet Oncol 4: 407-414, 2003.
11. Linja MJ and Visakorpi T: Alterations of androgen receptor in prostate cancer. J Steroid Biochem Mol Biol 92: 255-264, 2004.
12. Kiessling A, Hogrefe C, Erb S, et al: Expression, regulation and function of the ISGylation system in prostate cancer. Oncogene 28: 2606-2620, 2009
13. Bubendorf L, Kononen J, Koivisto P, et al: Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. Cancer Res 59: 803-806, 1999.
14. Edwards J, Krishna NS, Mukherjee R, Watters AD, Underwood MA and Bartlett JM: Amplification of the androgen receptor may not explain the development of androgen-independent prostate cancer. BJU Int 88: 633-637, 2001.
15. Koivisto P, Hyytinen E, Palmberg C, et al: Analysis of genetic changes underlying local recurrence of prostate carcinoma during androgen deprivation therapy. Am J Pathol 147: 1608-1614, 1995.
16. Feldman BJ and Feldman D: The development of androgen-independent prostate cancer. Nat Rev Cancer 1: 34-45, 2001.
17. Hyytinen ER, Haapala K, Thompson J, et al: Pattern of somatic androgen receptor gene mutations in patients with hormone-refractory prostate cancer. Lab Invest 82: 1591-1598, 2002.
18. Koivisto P, Kononen J, Palmberg C, et al: Androgen receptor gene amplification: A possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Cancer Res 57: 314-319, 1997.
19. Linja MJ, Savinainen KJ, Saramäki OR, Tammela TL, Vessella RL and Visakorpi T: Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer. Cancer Res 61: 3550-3555, 2001.
20. Leversha MA, Han J, Asgari Z, et al: Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer. Clin Cancer Res 15: 2091-2097, 2009.
21. Brown RS, Edwards J, Dogan A, et al: Amplification of the androgen receptor gene in bone metastases from hormone-refractory prostate cancer. J Pathol 198: 237-244, 2002.